Colorectal Liver Metastases
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, Folprecht G, Van Cutsem E, Ducreux M, Nordlinger B; European Organisation for Research and Treatment of Cancer (EORTC); Gastro-Intestinal Tract Cancer Group; Arbeitsgruppe Lebermetastasen und tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG).
RE: Local Treatment of Unresectable Colorectal Liver Metastases: Results of a RandomizedPhase II Trial. Macbeth F, Farewell V, Treasure T.
Progress and future direction in the management of advanced colorectal cancer G. M. Brown, M. J. Solomon First published: 13 April 2018
NICE Colorectal Cancer Quality Standard 20 [QS20], published August 2012
NICE guidance – Colorectal cancer: diagnosis and management (CG131), Last updated December 2014
Randomised multicentre trial of gadoxetic acid-enhanced MRI vs conventional MRI or CT in the staging of colorectal liver metastases, Zech CJ et al. British Journal of Surgery 2014, 101:613-21
Chemotherapy before liver resection of colorectal metastases – friend or foe? Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA. Annals of Surgery 2012, 255(2): 237-47.
One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Hamady ZZ, Lodge JP, Welsh FK, Toogood GJ, White A, John TG,. Rees M. Annals of Surgery 2014; 259(3):543-8.
Patient-reported outcomes after hepatic resection of colorectal liver metastases. Rees JR, Blazeby JM, Fayers P, Friend EA, Welsh FK, John TG, Rees M. J Clinical Oncology 2012; 30(12):1364-70.
Stereotactic body radiotherapy for liver metastases. Aitken KL, Hawkins MA, Clin Oncol (R Coll Radiol) 2015, 27(5):307-15
Impact of hepatobiliary service centralization on treatment and outcomes in patients with colorectal cancer and liver metastases E. Vallance J. vanderMeulen A. Kuryba I. D. Botterill J. Hill D. G. Jayne K. Walker
First published: 2 March 2017 https://doi.org/10.1002/bjs.10501
Cited by: 2 https://onlinelibrary.wiley.com/doi/full/10.1002/bjs.10501
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566patients with 1037 metastases. de Baère T, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiére J.
Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases. de Baère T, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiére J.
Systematic review and meta-analysis – Gonzalez et al., Annals of Surgical Oncology 2013;20:572-9
2925 patients 25 studies, 27%-68% OS 5 years.
Pasturino U, Buyse M, Friedel G, et al., Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997 Jan;113(1):37-49.
Gonzalez M, Poncet A Combescure C et al., Risk Factors for survival after lung metastasectomy in colorectal cancer patients: systematic review and meta-analysis. Ann Surg Oncol. 2013 Feb;20(2):572-9.
Surgery and ablative techniques for lung metastases in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) trial: is there equivalence? Treasure T et a., J Thorac Dis. 2016.
Prognostic factors after pulmonary metastasectomy of colorectal cancers: a single centre experience. Fournel L et al. J Thorac Dis. 2017.
Pulmonary metastasectomy: an overview Petrella F et al., J Thorac Dis 2017.
Molecular testing key papers:
Molecular testing in advanced/metastatic disease
RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group
Newton ACS Wong1, David Gonzalez2, Manuel Salto-Tellez3, Rachel Butler4, Salvador J Diaz-Cano5, Mohammad Ilyas6, William Newman7, Emily Shaw8, Philippe Taniere9, Shaun V Walsh10
Standards for integrated reporting in cellular pathology January 2017
Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing. Richman SD1, Chambers P, Seymour MT, Daly C, Grant S, Hemmings G, Quirke P.
Annual Report of the Chief Medical Officers 2016
Colorectal Peritoneal Metastases
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. Verwaal VJ1, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA.
Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. Elias D1, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, Lorimier G, Dubè P, Glehen O.
Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone R Mirnezami, A M Mehta, K Chandrakumaran, T Cecil, B J Moran, N Carr, V J Verwaal, F Mohamed & A H Mirnezami
Peritoneal metastases of lower GI tract origin… Ung L: J Cancer Res Clin Oncol 2013; 139:1899-1908
Peritoneal carcinomatosis of colorectal cancer… Massalou D: American Journal of Surgery 2017; 213:377-87
External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer. Segelman J: Colorectal Dis 2015; 18:378-85.
NICE guidance IPG 331 Cytoreduction surgery followed by hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis Feb 2010
NHS Commissioning A08/P/a Cytoreduction surgery for patients with peritoneal carcinomatosis April 3013
Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion. Rahul Rajeev, Brittany Klooster, and Kiran K. Turag J Gastrointest Oncol. 2016 Feb; 7(1): 122–128
A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin. Cao C, Yan TD, Black D, Morris DL. Ann Surg Oncol. 2009 Aug 12;16(8):2152–65
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, et al. Lancet Oncol. 2016;17(12):1709–19
Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Ann Surg. 2011 May;253(5):890-9.
Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer. PelvEx Collaborators (83)
Anastomotic Leaks After Restorative Resections for Rectal Cancer Compromise Cancer Outcomes and Survival. Lu ZR, Rajendran N, Lynch AC, Heriot AG, Warrier SK. Dis Colon Rectum. 2016 Mar;59(3):236-44.
Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013 Jul;100(8):1009-14.
Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013 Jul;100(8):E1-33.
Other papers collected by Pelican
The Fundamental Difference Between Cancer Treatment and Patient Care
Advances in surgical management for locally recurrent rectal cancer: How far have we come? Daniel Jin-Keat Lee, Peter M Sagar, Gaitri Sadadcharam, and Kok-Yang Tan
World J Gastroenterol. 2017 Jun 21; 23(23): 4170–4180.
Effect of specialist decision-making on treatment strategies for colorectal liver metastases Jones RP1, Vauthey JN, Adam R, Rees M, Berry D, Jackson R, Grimes N, Fenwick SW, Poston GJ, Malik HZ. Br J Surg. 2012 Nov;99(11):1605
Large variation in the utilization of liver resections in stage IV colorectal cancer patients with metastases confined to the liver AlibR.H.A.VerhoevencR.M.H. Roumend V.E.P.P. LemmenscA.M.Rijkenb, J.H.W.De Wilta
European Journal of Surgical Oncology (EJSO) Volume 41, Issue 9, September 2015, Pages 1217-1225
Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the Netherlands Lam-BoeraE.P. van der StokbJ. HuiskenscR.H.A., VerhoevendC.J.A., PunteM.A.G., ElferinkdJ.H, de WiltaC.Verhoefb
the CAIRO5/CHARISMA Group1
European Journal of Cancer Volume 71, January 2017, Pages 109-116
Treatment of colorectal peritoneal metastases requires multidisciplinary efforts Diane Goéré, Maximiliano Gelli
Lancet Oncology Volume 17, No. 12, p1630–1631, December 2016
Onco-Surgical Management of Liver Metastases from Colorectal Cancer
Population-based study on resection rates and survival in patients with colorectal liver metastasis in Norway J.-H. Angelsen, A. Horn, Sorbye, G. E. Eide, I. M. Løes, A. Viste
BJS First published: 9 February 2017 DOI: 10.1002/bjs.10457
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: from novelty to routine in selected cases – B Moran.
Techniques in Coloproctology. September 2017, Volume 21, Issue 9, pp 767–769 | Cite as